Article Versions Notes

Barrau M, Roblin X, Andromaque L, Rozieres A, Faure M, Paul S, Nancey S. What Should We Know about Drug Levels and Therapeutic Drug Monitoring during Pregnancy and Breastfeeding in Inflammatory Bowel Disease under Biologic Therapy? Journal of Clinical Medicine. 2023; 12(23):7495. https://doi.org/10.3390/jcm12237495

Barrau, Mathilde, Xavier Roblin, Leslie Andromaque, Aurore Rozieres, Mathias Faure, Stéphane Paul, and Stéphane Nancey. 2023. "What Should We Know about Drug Levels and Therapeutic Drug Monitoring during Pregnancy and Breastfeeding in Inflammatory Bowel Disease under Biologic Therapy?" Journal of Clinical Medicine 12, no. 23: 7495. https://doi.org/10.3390/jcm12237495

Barrau, M., Roblin, X., Andromaque, L., Rozieres, A., Faure, M., Paul, S., & Nancey, S. (2023). What Should We Know about Drug Levels and Therapeutic Drug Monitoring during Pregnancy and Breastfeeding in Inflammatory Bowel Disease under Biologic Therapy? Journal of Clinical Medicine, 12(23), 7495. https://doi.org/10.3390/jcm12237495